Funds managed by Invesco Asset Management Limited participate in $27 million Series C financing round of Vedanta Biosciences
Clients Invesco Asset Management Limited
Jones Day advised funds managed by Invesco Asset Management Limited in connection with their participation in the $27 million Series C financing round of Vedanta Biosciences, Inc., a clinical-stage company developing therapies for immune-mediated diseases based on human microbiome-derived bacteria.